Clinical Trial Update: Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating zanidatamab given before surgery for HER2-positive colon and rectal cancer planned for curative-intent treatment; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Zanidatamab

Snippet

Sponsor: Emory University | Conditions: Colon Carcinoma, Colorectal Carcinoma | Phase 2 | Status: RECRUITING